Anna Kamińska
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Anna Kamińska has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
- Biruta Kierdaszuk
Department of Neurology, Medical University of Warsaw, Warsaw, Poland
5 shared publications Hubert Kwieciński
Department of Neurology, Medical University of Warsaw, Warsaw, Poland
4 shared publications- Anna Kostera-Pruszczyk
Department of Neurology, Medical University of Warsaw, Poland
3 shared publications - Cezary Żekanowski
Department of Neurogenetics and Functional Genomics, Mossakowski Medical Research Institute, Polish Academy of Sciences, Warsaw, Poland
3 shared publications - Ewa Bartnik
Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 02-106 Warsaw, Poland
3 shared publications - Katarzyna Tońska
Institute of Genetics and Biotechnology, Faculty of Biology, University of Warsaw, 02-106 Warsaw, Poland
3 shared publications
Latest Publications
- Open Access
Progressive External Ophthalmoplegia in Polish Patients—From Clinical Evaluation to Genetic Confirmation
Mitochondrial encephalomyopathies comprise a group of heterogeneous disorders resulting from impaired oxidative phosphorylation (OxPhos). Among a variety of symptoms progressive external ophthalmoplegia (PEO) seems to be the most common. The aim of this study is to present clinical and genetic characteristics of Polish patients with PEO. Clinical, electrophysiological, neuroradiological, and morphological data of 84 patients were analyzed. Genetic studies of mitochondrial DNA (mtDNA) were performed in all patients. Among nuclear DNA (nDNA) genes POLG was sequenced in 41 patients, TWNK (C10orf2) in 13 patients, and RNASEH1 in 2 patients. Total of 27 patients were included in the chronic progressive external ophthalmoplegia (CPEO) group, 24 in the CPEO+ group. Twenty-six patients had mitochondrial encephalomyopathy (ME), six patients Kearns–Sayre syndrome (KSS), and one patient sensory ataxic neuropathy, dysarthria, ophthalmoparesis (SANDO) syndrome. Genetic analysis of nDNA genes revealed the presence of pathogenic or possibly pathogenic variants in the POLG gene in nine patients, the TWNK gene in five patients and the RNASEH1 gene in two patients. Detailed patients’ history and careful assessment of family history are essential in the diagnostic work-up. Genetic studies of both mtDNA and nDNA are necessary for the final diagnosis of progressive external ophthalmoplegia and for genetic counseling.
Open AccessProgressive External Ophthalmoplegia in Polish Patients—From Clinical Evaluation to Genetic Confirmation
Mitochondrial encephalomyopathies comprise a group of heterogeneous disorders resulting from impaired oxidative phosphorylation (OxPhos). Among a variety of symptoms progressive external ophthalmoplegia (PEO) seems to be the most common. The aim of this study is to present clinical and genetic characteristics of Polish patients with PEO. Clinical, electrophysiological, neuroradiological, and morphological data of 84 patients were analyzed. Genetic studies of mitochondrial DNA (mtDNA) were performed in all patients. Among nuclear DNA (nDNA) genes POLG was sequenced in 41 patients, TWNK (C10orf2) in 13 patients, and RNASEH1 in 2 patients. Total of 27 patients were included in the chronic progressive external ophthalmoplegia (CPEO) group, 24 in the CPEO+ group. Twenty-six patients had mitochondrial encephalomyopathy (ME), six patients Kearns–Sayre syndrome (KSS), and one patient sensory ataxic neuropathy, dysarthria, ophthalmoparesis (SANDO) syndrome. Genetic analysis of nDNA genes revealed the presence of pathogenic or possibly pathogenic variants in the POLG gene in nine patients, the TWNK gene in five patients and the RNASEH1 gene in two patients. Detailed patients’ history and careful assessment of family history are essential in the diagnostic work-up. Genetic studies of both mtDNA and nDNA are necessary for the final diagnosis of progressive external ophthalmoplegia and for genetic counseling.
- Open Access
Texture Analysis of Dystrophic Muscle Biopsies
Despite the introduction of a full range of genetic diagnostic tests and sophisticated techniques in modern pathology, interpretation of histopathological images obtained from muscle biopsies remains important in the daily practice of neuropathology since it can give indications of the severity and the rate of progression of neuromuscular disease. In this paper, we propose a simple and time saving method for quantitative assessment of severity of Duchenne Muscular Dystrophy (DMD) based on computer-aided analysis of histopathological images obtained from biopsies of dystrophic muscles. Using this method, c olour f iltration p ixel-by- p ixel of the whole virtual slides ( CFPP method ) is adopted to semi-quantitative evaluation of morphological structure of the muscular tissue. Results demonstrate usefulness of the proposed method in neuropathological assessement of DMD severity.
Open AccessTexture Analysis of Dystrophic Muscle Biopsies
Despite the introduction of a full range of genetic diagnostic tests and sophisticated techniques in modern pathology, interpretation of histopathological images obtained from muscle biopsies remains important in the daily practice of neuropathology since it can give indications of the severity and the rate of progression of neuromuscular disease. In this paper, we propose a simple and time saving method for quantitative assessment of severity of Duchenne Muscular Dystrophy (DMD) based on computer-aided analysis of histopathological images obtained from biopsies of dystrophic muscles. Using this method, c olour f iltration p ixel-by- p ixel of the whole virtual slides ( CFPP method ) is adopted to semi-quantitative evaluation of morphological structure of the muscular tissue. Results demonstrate usefulness of the proposed method in neuropathological assessement of DMD severity.
- 1 November 2016
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 50 (6) , 468-473
CAV3 mutation in a patient with transient hyperCKemia and myalgia
Mutations in caveolin-3 (CAV3) can lead to different clinical phenotypes affecting skeletal or cardiac muscles. Here, we describe a patient with Klinefelter syndrome, ulcerative colitis and Sjögren syndrome, who developed transient hyperCKemia, myalgia and mild muscular weakness. Using whole exome sequencing (WES), a missense mutation G169A was found in the CAV3 gene. In addition, we identified a homozygous frameshift deletion in MS4A12 that may contribute to inflammatory bowel disease, further demonstrating usefulness of WES in dual molecular diagnoses.
- 1 November 2016
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 50 (6) , 468-473
CAV3 mutation in a patient with transient hyperCKemia and myalgia
Mutations in caveolin-3 (CAV3) can lead to different clinical phenotypes affecting skeletal or cardiac muscles. Here, we describe a patient with Klinefelter syndrome, ulcerative colitis and Sjögren syndrome, who developed transient hyperCKemia, myalgia and mild muscular weakness. Using whole exome sequencing (WES), a missense mutation G169A was found in the CAV3 gene. In addition, we identified a homozygous frameshift deletion in MS4A12 that may contribute to inflammatory bowel disease, further demonstrating usefulness of WES in dual molecular diagnoses.
- 12 January 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (2) , 116-117
Irena Hausmanowa-Petrusewicz, MD, PhD (1917–2015)
- 12 January 2016
- Published by Wolters Kluwer Health in Neurology
- Vol. 86 (2) , 116-117
Irena Hausmanowa-Petrusewicz, MD, PhD (1917–2015)
- Open Access
- 8 January 2016
- Published by Springer Nature in Human Genomics
- Vol. 10 (1) , 1-9
Genetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes
Migraine is the most common neurological disorder, affecting approximately 12 % of the adult population worldwide, caused by both environmental and genetic factors. Three causative genes have been identified in familial hemiplegic migraine (FHM) families: CACNA1A, ATP1A2, and SCNA1A. Recently, several mutations in KCNK18 have also been found as causative factors in migraine development. The aim of our study was to identify the genetic background of migraine in the Polish population. Sixty patients with migraine without aura (MO) or with different types of migraine with aura (MA), including sporadic hemiplegic, familial hemiplegic, and probable familial hemiplegic, were screened for mutations in the four genes previously linked with different types of migraine (ATP1A2, CACNA1A, SCN1A, and KCNK18). Two missense mutations were found. One novel mutation in SCN1A, encoding α subunit of sodium channel, causing amino acid change M1500V localized to a region encoding inactivation loop between transmembrane domains III and IV of the channel, was detected in a female FHM patient. The M1500V mutation was absent in a group of 62 controls, as well as in the ExAC database. The second, already known missense mutation S231P in KCNK18 was found in a female MA patient. Additionally, a novel intronic polymorphism possibly affecting alternative splicing of SCN1A, at chr2:16685249, g.77659T>C, and c.4581+32A>G, located between exons 24 and 25, in a region encoding the inactivation loop of the sodium channel was found in a female MO patient. No mutations in ATP1A2 or CACNA1A were found in the study group. The presence of SCN1A mutations and absence of mutations in ATP1A2 or CACNA1A suggest that the Polish patients represent FHM type 3. On the other hand, the presence of KCNK18 mutation indicated another FHM subtype. It could be speculated that contrary to other European populations, the genetic basis of migraine in the Polish population involves mutations in genes not included in the study. Next-generation sequencing methods should be implemented to identify other migraine-associated variants.
- 8 January 2016
- Published by Springer Nature in Human Genomics
- Vol. 10 (1) , 1-9
Open AccessGenetic studies of Polish migraine patients: screening for causative mutations in four migraine-associated genes
Migraine is the most common neurological disorder, affecting approximately 12 % of the adult population worldwide, caused by both environmental and genetic factors. Three causative genes have been identified in familial hemiplegic migraine (FHM) families: CACNA1A, ATP1A2, and SCNA1A. Recently, several mutations in KCNK18 have also been found as causative factors in migraine development. The aim of our study was to identify the genetic background of migraine in the Polish population. Sixty patients with migraine without aura (MO) or with different types of migraine with aura (MA), including sporadic hemiplegic, familial hemiplegic, and probable familial hemiplegic, were screened for mutations in the four genes previously linked with different types of migraine (ATP1A2, CACNA1A, SCN1A, and KCNK18). Two missense mutations were found. One novel mutation in SCN1A, encoding α subunit of sodium channel, causing amino acid change M1500V localized to a region encoding inactivation loop between transmembrane domains III and IV of the channel, was detected in a female FHM patient. The M1500V mutation was absent in a group of 62 controls, as well as in the ExAC database. The second, already known missense mutation S231P in KCNK18 was found in a female MA patient. Additionally, a novel intronic polymorphism possibly affecting alternative splicing of SCN1A, at chr2:16685249, g.77659T>C, and c.4581+32A>G, located between exons 24 and 25, in a region encoding the inactivation loop of the sodium channel was found in a female MO patient. No mutations in ATP1A2 or CACNA1A were found in the study group. The presence of SCN1A mutations and absence of mutations in ATP1A2 or CACNA1A suggest that the Polish patients represent FHM type 3. On the other hand, the presence of KCNK18 mutation indicated another FHM subtype. It could be speculated that contrary to other European populations, the genetic basis of migraine in the Polish population involves mutations in genes not included in the study. Next-generation sequencing methods should be implemented to identify other migraine-associated variants.
- Open Access
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Folia Neuropathologica
- Vol. 4 (4) , 355-366
Sporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients
Introduction : Sporadic inclusion body myositis (sIBM) is one of the most common myopathies in patients above 50 years of age. Its progressive course finally leads to immobilisation, and no effective therapy exists. Its pathogenesis includes both degenerative and inflammatory processes,...
- 1 January 2015
- Published by Termedia Sp. z.o.o. in Folia Neuropathologica
- Vol. 4 (4) , 355-366
Open AccessSporadic inclusion body myositis: clinical, pathological, and genetic analysis of eight Polish patients
Introduction : Sporadic inclusion body myositis (sIBM) is one of the most common myopathies in patients above 50 years of age. Its progressive course finally leads to immobilisation, and no effective therapy exists. Its pathogenesis includes both degenerative and inflammatory processes,...
- 1 January 2014
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 48 (1) , 76-80
Mitochondrial encephalomyopathy: Towards diagnosis. A case report
Mitochondrial diseases may cause a wide range of central and peripheral nervous system disorders, as well as muscle disorders. The diagnostic workup routinely includes electrophysiological, morphological, neuroimaging and genetic studies. In some cases, the diagnosis may be ascertained only when mitochondrial DNA (mtDNA) examination in the muscle is performed. We report on a case of a 24-year-old woman, with a 7-year history of slowly progressive cerebellar syndrome and bilateral ptosis. Mitochondrial encephalomyopathy was suspected, based on the clinical picture and results of examinations, but the typical red ragged fibers were not found in the muscle biopsy. The results of molecular analysis of mtDNA showed a mtDNA deletion in the muscle and, on a level detectable only with polymerase chain reaction method, in blood leukocytes. This case emphasizes the important role of mtDNA studies in muscle in nonspecific multisystem mitochondrial disorders, even without clinical muscle involvement.
- 1 January 2014
- Published by VM Media Group sp. z o.o in Neurologia i Neurochirurgia Polska
- Vol. 48 (1) , 76-80
Mitochondrial encephalomyopathy: Towards diagnosis. A case report
Mitochondrial diseases may cause a wide range of central and peripheral nervous system disorders, as well as muscle disorders. The diagnostic workup routinely includes electrophysiological, morphological, neuroimaging and genetic studies. In some cases, the diagnosis may be ascertained only when mitochondrial DNA (mtDNA) examination in the muscle is performed. We report on a case of a 24-year-old woman, with a 7-year history of slowly progressive cerebellar syndrome and bilateral ptosis. Mitochondrial encephalomyopathy was suspected, based on the clinical picture and results of examinations, but the typical red ragged fibers were not found in the muscle biopsy. The results of molecular analysis of mtDNA showed a mtDNA deletion in the muscle and, on a level detectable only with polymerase chain reaction method, in blood leukocytes. This case emphasizes the important role of mtDNA studies in muscle in nonspecific multisystem mitochondrial disorders, even without clinical muscle involvement.
- Open Access
- 23 September 2013
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 14 (1) , 78
Internal jugular vein valve insufficiency is not increased in migraine: an ultrasound study in migraine patients and control participants
Migraine is a common neurological disorder of unclear pathogenesis. Recently incompetence of internal jugular vein valve (IJVVI) was found to be associated with some neurological conditions of unknown etiology such as benign cough headache, primary exertional headache or transient global amnesia. Common vascular mechanism linking transiently increased cerebral venous pressure with the above mentioned conditions was then postulated. Therefore we decided to investigate whether IJVVI may be associated with migraine.
- 23 September 2013
- Published by Springer Nature in The Journal of Headache and Pain
- Vol. 14 (1) , 78
Open AccessInternal jugular vein valve insufficiency is not increased in migraine: an ultrasound study in migraine patients and control participants
Migraine is a common neurological disorder of unclear pathogenesis. Recently incompetence of internal jugular vein valve (IJVVI) was found to be associated with some neurological conditions of unknown etiology such as benign cough headache, primary exertional headache or transient global amnesia. Common vascular mechanism linking transiently increased cerebral venous pressure with the above mentioned conditions was then postulated. Therefore we decided to investigate whether IJVVI may be associated with migraine.
- 1 March 2013
- Published by Elsevier in Neuromuscular Disorders
- Vol. 23 (3) , 219-228
A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy
- 1 March 2013
- Published by Elsevier in Neuromuscular Disorders
- Vol. 23 (3) , 219-228
A novel mutation in the DNM2 gene impairs dynamin 2 localization in skeletal muscle of a patient with late onset centronuclear myopathy
- 10 July 2012
- Vol. 46 (3)
[Elevated plasma creatine kinase activity - does it always indicate muscle disease?].
- 10 July 2012
- Vol. 46 (3)
[Elevated plasma creatine kinase activity - does it always indicate muscle disease?].